Adma Biologics ADMA Cash Flow Statement (2011-2026)

NASDAQ ADMA
$12.79 +0.06 (+0.47%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Adma Biologics Quarterly Cash Flow Statement

Periods 53 quarters
Latest Sep 2026

Adma Biologics reported cash from operations of $17.37M and free cash flow of $15.37M for the quarter ended Sep 2026, up 30.7% year over year. This cash flow statement covers 53 quarters of results from Mar 2011 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-16.65M-25.01M-13.76M-14.90M-12.23M-6.79M-6.37M2.57M-17.65M17.81M32.06M35.91M111.90M26.90M34.22M36.43M49.38M45.33M37.82M49.88M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.50M0.58M0.34M0.98M0.49M0.49M0.69M0.72M0.70M0.25M0.23M0.25M0.22M0.19M0.16M0.17M0.20M0.19M0.19M0.21M
Depreciation & Amortization (CF)Dep. & Amort.
1.52M1.59M1.72M1.86M1.94M2.03M2.10M2.09M2.11M2.11M2.05M1.94M1.94M1.97M2.06M2.02M2.05M1.84M1.78M1.79M
Share-based CompensationStock Comp.
1.21M1.64M1.19M1.31M1.07M1.11M1.64M1.70M1.75M2.14M2.86M3.18M5.43M4.62M4.96M5.05M5.39M6.33M6.14M6.20M
Deferred Taxes
-84.28M3.43M1.62M4.80M1.17M3.29M0.00M-0.73M
Gains from Sales and DivestituresGains Divest
-0.14M0.00M-638.00-0.01M-0.42M-0.02M-0.09M-0.07M-0.02M0.00M-0.01M-0.07M-0.01M8.00M-8.04M
Gains from Investment SecuritiesGains Investment
7.98M
Other non-cash itemsOther Non-Cash
-0.04M6.63M0.94M0.94M27.02M-0.04M1.21M-0.04M1.16M2.18M-0.04M-0.04M
Change in Working Capital
Change in ReceivablesChange Receivables
8.18M-2.95M-6.75M2.02M-5.40M11.01M10.21M-5.41M-3.90M22.20M-19.51M20.03M-0.14M49.41M10.31M27.95M20.76M-22.57M2.37M30.99M
Change in InventoryChange Inventory
10.60M14.42M6.93M16.84M0.37M0.71M-2.21M1.34M9.79M4.83M2.08M-8.01M-1.57M1.95M19.28M5.20M9.80M15.63M17.22M26.80M
Change in Account PayablesChange Payables
-4.85M1.69M-2.73M13.81M-11.97M-0.27M-0.87M-0.01M4.99M0.45M-1.86M1.62M3.94M0.14M9.27M-4.88M-2.20M-1.23M10.08M4.11M
Change in Accrued ExpensesChange Accrued Exp.
2.81M-1.78M0.31M2.13M6.87M-1.35M6.09M0.14M2.66M0.77M-5.97M-0.19M6.43M-2.40M-2.81M-0.22M10.64M5.11M-6.58M15.15M
Change in Other Operating AssetsOther Assets Change
-0.56M-0.22M0.59M0.46M-0.20M-1.01M2.17M0.07M-2.07M-0.61M0.87M4.36M-1.94M2.48M-0.08M-1.16M0.01M1.22M-0.02M1.12M
Change in Other Operating LiabilitiesOther Liabilities Change
0.11M-0.11M-0.14M-0.11M-0.14M-0.19M-0.11M-0.27M-0.23M0.68M-0.26M-1.27M-0.29M-0.65M0.05M-0.23M-0.40M-0.34M-0.29M-0.30M
Other Working Capital ChangesOther WC Changes
0.67M0.11M-0.74M-0.57M0.07M0.82M-2.27M-0.34M1.84M1.29M-1.13M-5.63M1.65M-3.13M0.12M0.93M-0.40M-1.56M-0.27M-1.42M
Cash from OperationsCash from Ops.
-33.47M-26.01M-12.83M-13.28M-7.38M-14.72M-6.06M11.99M17.60M-2.22M45.65M25.03M50.22M-19.68M21.14M13.29M35.64M58.25M29.54M17.37M
Investing Activities
Capital ExpendituresCapex
3.68M2.84M3.94M3.38M3.75M1.95M0.87M0.76M1.20M2.35M2.07M1.06M2.76M4.70M2.42M14.37M1.08M2.54M2.26M2.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
5.00M
Change in Property, Plant and EquipmentChange in PP&E
-3.68M-2.84M-3.94M-3.38M-3.75M-1.95M-0.87M-0.76M-1.20M-2.35M-2.07M-1.06M-2.76M-4.70M-2.42M-14.37M-1.08M2.46M-2.26M-2.00M
Change in IntangiblesChange Intangibless
0.21M0.02M0.30M0.04M-0.01M0.02M0.11M0.19M0.05M0.07M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
-3.68M-2.84M-3.94M-3.38M-3.75M-1.95M-0.87M-0.76M-1.41M-2.36M-2.37M-1.10M-2.75M-4.72M-2.53M-14.37M-0.28M2.40M-2.26M-2.07M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
151.75M135.00M-75.00M125.00M
Long-Term Debt RepaymentsLT Debt Repayment
0.01M100.01M0.01M0.01M0.01M0.01M0.01M0.00M30.00M-30.00M30.00M2.97M-32.97M0.47M0.47M0.94M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.01M51.74M-0.01M-0.01M-0.01M-0.01M-0.01M135.00M-30.00M30.00M-30.00M-2.97M-42.03M124.53M-0.47M-0.94M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.94M
Short-Term Debt issuancesST Debt Issuance
75.00M-75.00M
Net Short-Term Debt Issued (Repaid)Net ST Debt
75.00M-75.00M
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M
Shares Repurchased
25.06M
Net Shares Issued and RepurchasedNet Shares Issued
-25.05M
Net Equity Issued and RepurchasedNet Equity Issued
-25.05M
Other financing activities (as filed)
-0.78M
Cash from Financing ActivitiesCash from Financing
-26.77M
Additional items
Change in Cash
-11.47M
Ending Cash Balance
124.56M
Free Cash FlowFCF
15.37M
Net Cash FlowNCF
-11.47M
Interest Paid

Adma Biologics Cash Flow Statement API

Pull Adma Biologics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADMA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY